Piramal Pharma Shareholding

Piramal Pharma Ltd Shareholding Pattern

The Piramal Pharma Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Piramal Pharma Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.

Piramal Pharma Ltd (NSE: PPLPHARMA, BSE: 543635) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Piramal Pharma Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.

Piramal Pharma Ltd Shareholding Pattern (Latest)

The latest Piramal Pharma Ltd shareholding for Mar 2026 is:

• Promoters: 34.86%
• FII: 30.18%
• DII: 15.61%
• Public: 19.35%
• Government: 0.00%

Promoter holding in Piramal Pharma Ltd remains stable, reflecting consistent long-term commitment.

Piramal Pharma Ltd Promoter Holding Trend

Promoter shareholding plays a crucial role in evaluating management confidence in Piramal Pharma Ltd.

• Mar 2026: 34.86%
• Dec 2025: 34.86%
• Sept 2025: 34.86%
• Jun 2025: 34.86%
• Mar 2025: 34.95%

Promoter stake remains largely stable, showing consistent ownership structure.

Piramal Pharma Ltd FII Shareholding Trend

Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Piramal Pharma Ltd.

• Mar 2026: 30.18%
• Dec 2025: 29.66%
• Sept 2025: 30.27%
• Jun 2025: 30.86%
• Mar 2025: 31.49%

FII holding in Piramal Pharma Ltd has increased recently, indicating rising foreign investor interest.

Piramal Pharma Ltd DII Shareholding Trend

Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.

• Mar 2026: 15.61%
• Dec 2025: 15.69%
• Sept 2025: 14.89%
• Jun 2025: 14.26%
• Mar 2025: 14.78%

DII holdings remain stable, reflecting steady institutional participation.

Piramal Pharma Ltd Public Shareholding Trend

Public shareholding represents retail and non-institutional investors.

• Mar 2026: 19.35%
• Dec 2025: 19.80%
• Sept 2025: 19.98%
• Jun 2025: 20.02%
• Mar 2025: 18.78%

Public holding remains stable with consistent retail participation.

Piramal Pharma Ltd Government Holding

Government holding in Piramal Pharma Ltd currently stands at 0.00%.

Piramal Pharma Ltd operates without significant government ownership.

Piramal Pharma Ltd Shareholding Analysis Summary

The Piramal Pharma Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.

Investors should monitor changes in Piramal Pharma Ltd shareholding for signals on institutional sentiment and ownership trends.

Regular monitoring of the Piramal Pharma Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.